Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Urologic Oncology|October 13, 2014
Income inequality and treatment of African American men with high-risk prostate cancerDavid R Ziehr, Brandon A Mahal, Ayal A Aizer, et al.Urologic Oncology|May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imagingVinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.BJU International|April 8, 2015
Risk of prostate cancer mortality in men with a history of prior cancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.Brachytherapy|June 2, 2014
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term resultsBrandon A Mahal, David R Ziehr, Andrew S Hyatt, et al.Science (New York, N.Y.)|July 17, 2025
Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disordersJason Yang, Yunhan Xu, David R Ziehr, et al.The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.Biorxiv : the Preprint Server for Biology|May 7, 2024
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosisDavid R Ziehr, Fei Li, K Mark Parnell, et al.Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.Pageof 3